FRTD Stock Overview
Fortitude Group Inc. develops solutions for the medical community.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Fortitude Group, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.000001 |
52 Week High | US$0.0001 |
52 Week Low | US$0.000001 |
Beta | 0 |
1 Month Change | 0% |
3 Month Change | -90.00% |
1 Year Change | 0% |
3 Year Change | -99.75% |
5 Year Change | 0% |
Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
FRTD | US Capital Markets | US Market | |
---|---|---|---|
7D | 0% | -0.7% | -3.2% |
1Y | 0% | 23.2% | 19.3% |
Return vs Industry: FRTD underperformed the US Capital Markets industry which returned 23.2% over the past year.
Return vs Market: FRTD underperformed the US Market which returned 19.3% over the past year.
Price Volatility
FRTD volatility | |
---|---|
FRTD Average Weekly Movement | n/a |
Capital Markets Industry Average Movement | 3.4% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.5% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: FRTD's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine FRTD's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | Thomas Parilla | n/a |
Fortitude Group Inc. develops solutions for the medical community. The company, through its direct holdings, subsidiaries, and joint ventures, focuses on utilizing a product portfolio that would include medical devices, and advanced technology and medical protocol procedures, which are engineered to prevent risk and improve patient outcomes. The company was formerly known as Rounder, Inc. and changed its name to Fortitude Group, Inc. in January 2013.
Fortitude Group, Inc. Fundamentals Summary
FRTD fundamental statistics | |
---|---|
Market cap | US$737.00 |
Earnings (TTM) | -US$92.60k |
Revenue (TTM) | n/a |
0.0x
P/S Ratio0.0x
P/E RatioIs FRTD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
FRTD income statement (TTM) | |
---|---|
Revenue | US$0 |
Cost of Revenue | US$0 |
Gross Profit | US$0 |
Other Expenses | US$92.60k |
Earnings | -US$92.60k |
Last Reported Earnings
Mar 31, 2012
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did FRTD perform over the long term?
See historical performance and comparison